127 related articles for article (PubMed ID: 799764)
1. Nonspecific antigen reactions.
Klein E; Rosner D; Holtermann OA; Stoll HL; Song SY
Natl Cancer Inst Monogr; 1976 Nov; 44():87-97. PubMed ID: 799764
[TBL] [Abstract][Full Text] [Related]
2. Immunologic approaches to various types of cancer with the use of BCG and purified protein derivatives.
Klein E; Holtermann OA; Papermaster B; Milgrom H; Rosner D; Klein L; Walker MJ; Zbar B
Natl Cancer Inst Monogr; 1973 Dec; 39():229-42. PubMed ID: 4595323
[No Abstract] [Full Text] [Related]
3. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Nathanson L; Clark DA
Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
[No Abstract] [Full Text] [Related]
4. Introduction: Immunotherapy of cancer in man, a reality.
Klein E
Natl Cancer Inst Monogr; 1973 Dec; 39():139-61. PubMed ID: 4206961
[No Abstract] [Full Text] [Related]
5. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
6. Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
Vonderheid EC; Van Scott EJ; Johnson WC; Grekin DA; Asbell SO
Arch Dermatol; 1977 Apr; 113(4):454-62. PubMed ID: 848974
[TBL] [Abstract][Full Text] [Related]
7. Regression of cutaneous neoplasms following delayed-type hypersensitivity challenge reactions to microbial antigens or lymphokines.
Holtermann OA; Papermaster B; Rosner D; Milgrom H; Klein E
J Med; 1975; 6(2):157-68. PubMed ID: 1099159
[TBL] [Abstract][Full Text] [Related]
8. A technique for intensifying BCG sensitivity.
Parmett SR; Klein E
J Med; 1975; 6(3-4):213-6. PubMed ID: 1104733
[TBL] [Abstract][Full Text] [Related]
9. [Current status of immunotherapy of malignant tumors].
Flad HD; Betzler M; Herfarth C
Chirurg; 1979 Jan; 50(1):11-5. PubMed ID: 367730
[No Abstract] [Full Text] [Related]
10. Immunotherapeutic approaches to the management of neoplasms.
Klein E; Holtermann OA
Natl Cancer Inst Monogr; 1972 Dec; 35():379-402. PubMed ID: 4572833
[No Abstract] [Full Text] [Related]
11. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
[TBL] [Abstract][Full Text] [Related]
12. Nonspecific immunotherapy of malignant tumors.
Milas L; Withers HR
Radiology; 1976 Jan; 118(1):211-8. PubMed ID: 1105663
[TBL] [Abstract][Full Text] [Related]
13. BCG in cancer and leukemia treatment and prophylaxis-A review.
Rosenthal SR
J Med; 1975; 6(3-4):193-212. PubMed ID: 1104732
[TBL] [Abstract][Full Text] [Related]
14. The immune response and cancer. A guide.
Gilbert HA; Kagan AR
Radiol Clin Biol; 1974; 43(5):409-44. PubMed ID: 4605271
[No Abstract] [Full Text] [Related]
15. [Immunotherapy of malignant melanoma (active specific and non-specific immune stimulation) (author's transl)].
Kokoschka EM; Micksche M
Wien Klin Wochenschr; 1976 Nov; 88(21):690-6. PubMed ID: 1007279
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for accessible tumors utilizing delayed hypersensitivity reactions and separated components of the immune system.
Klein E; Holtermann O; Milgrom H; Case RW; Klein D; Rosner D; Djerassi I
Med Clin North Am; 1976 May; 60(3):389-418. PubMed ID: 1271886
[TBL] [Abstract][Full Text] [Related]
17. Some immunologically based reactions that can cause the regression of large tumor masses.
Alexander P
Natl Cancer Inst Monogr; 1976 Nov; 44():105-8. PubMed ID: 799755
[TBL] [Abstract][Full Text] [Related]
18. [A malignus melanoma immunterápiájának lehetoségei].
Ladányi A
Magy Onkol; 2003; 47(1):113-7. PubMed ID: 12704464
[TBL] [Abstract][Full Text] [Related]
19. Immune response and non-specific immunotherapy in melanoma.
El-Domeiri AA
Ann R Coll Surg Engl; 1978 Mar; 60(2):117-20. PubMed ID: 637492
[TBL] [Abstract][Full Text] [Related]
20. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
[No Abstract] [Full Text] [Related]
[Next] [New Search]